TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,288 | -8.8% | 665 | -7.4% | 0.00% | 0.0% |
Q2 2023 | $11,280 | +21.1% | 718 | +27.1% | 0.00% | +100.0% |
Q1 2023 | $9,312 | +5.7% | 565 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $8,814 | +25.9% | 565 | +12.3% | 0.00% | 0.0% |
Q3 2022 | $7,000 | -41.7% | 503 | -39.3% | 0.00% | -50.0% |
Q2 2022 | $12,000 | 0.0% | 828 | -0.5% | 0.00% | 0.0% |
Q1 2022 | $12,000 | +33.3% | 832 | +29.6% | 0.00% | +100.0% |
Q4 2021 | $9,000 | -18.2% | 642 | -2.3% | 0.00% | -50.0% |
Q3 2021 | $11,000 | +37.5% | 657 | +31.9% | 0.00% | +100.0% |
Q2 2021 | $8,000 | -33.3% | 498 | -25.4% | 0.00% | -50.0% |
Q1 2021 | $12,000 | 0.0% | 668 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $12,000 | 0.0% | 668 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $12,000 | 0.0% | 668 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $12,000 | +20.0% | 668 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $10,000 | -23.1% | 668 | 0.0% | 0.00% | +100.0% |
Q4 2019 | $13,000 | – | 668 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |